United States

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

25 Apr 2018
Change (% chg)

¥0.33 (+4.99%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills,... (more)
No analyst recommendations are available for .


Beta: 0.85
Market Cap(Mil.): ¥17,630.99
Shares Outstanding(Mil.): 2,667.32
Dividend: 0.12
Yield (%): 1.82


  600572.SS Industry Sector
P/E (TTM): 27.75 29.65 32.31
EPS (TTM): 0.24 -- --
ROI: 9.81 13.36 12.97
ROE: 13.31 15.09 14.84

BRIEF-Zhejiang Conba Pharmaceutical's Share Trade To Resume On April 18

* SAYS SHARE TRADE TO RESUME ON APRIL 18 Source text in Chinese: https://bit.ly/2HIphKM Further company coverage: (Reporting by Hong Kong newsroom)

Apr 17 2018

BRIEF-Zhejiang Conba Pharmaceutical's Consortium Acquires Stake In Jiangxi Chinese Medicine Firm

* SAYS ITS CONSORTIUM ACQUIRES 41 PERCENT STAKE IN JIANGXI CHINESE MEDICINE FIRM FOR 300.35 MILLION YUAN ($47.84 million) Source text in Chinese: https://bit.ly/2v9X0Kh Further company coverage: ($1 = 6.2785 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Apr 13 2018

BRIEF-Zhejiang Conba Pharmaceutical Says Lock-Up Period For 446.25 Million Shares To End

* SAYS LOCK-UP PERIOD FOR 446.25 MILLION SHARES TO END, SHARES TO START TRADING ON APRIL 16 Source text in Chinese: https://bit.ly/2EA5Yjp Further company coverage: (Reporting by Hong Kong newsroom)

Apr 10 2018

BRIEF-Zhejiang CONBA Pharmaceutical to set up traditional Chinese medicinal materials unit in Zhejiang

* Says it plans to invest 100 million yuan to set up a wholly owned traditional Chinese medicinal materials unit in Zhejiang

Mar 13 2018

BRIEF-Zhejiang Conba Pharmaceutical issues 156.6 mln shares and raises 1.09 bln yuan

* Says it issued 156.6 million shares and raised 1.09 billion yuan in total, via private placement

Jan 12 2018

BRIEF-Zhejiang Conba Pharmaceutical Sees 2017 Net Profit Up 60-80 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO RISE 60-80 PERCENT Y/Y FROM 441.1 MILLION YUAN ($67.65 million) YEAR AGO Source text in Chinese: http://bit.ly/2CRWSBQ Further company coverage: ($1 = 6.5205 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Jan 09 2018

BRIEF-Zhejiang Conba Pharmaceutical two units obtains high-tech enterprise recognition

* Says its two wholly owned Guizhou and Inner Mongolia-based pharma units obtains high-tech enterprise recognition, to enjoy a tax preference of 15 percent for three years from 2017 to 2019

Dec 22 2017

Earnings vs. Estimates